Offers access to exclusive, in-depth coverage of early science and clinical trials, pharma and biotech news on Wall Street, policy development in Washington, and disruption in health care in Silicon Valley and beyond. Requires registration with a Yale email address.
Leading source for breaking news and in-depth analysis on emerging life science tools and diagnostics. Premium Access is available to affiliates of non-profit organizations and academic institutions. Register with your Yale email address for access.